After spending most of his 20s as a Navy SEAL deploying overseas, George Hodgin found himself at Stanford Business School. While helping a fellow veteran navigate challenges with PTSD, despite significant anecdotal evidence touting marijuana's benefits to those recovering from mental illness, George discovered there was little scientific research related to marijuana and PTSD recovery.

It turns out there was a significant gap in the market for cannabis.  Inspired by his friend and a class project, George created the Biopharmaceutical Research Company to create a pathway for academic researchers to access cannabis for medical research. After years of regulatory uncertainty, BRC is now poised to be a leading provider of cannabis to medical research facilities across the United States. In this episode, we discuss:

+The challenges veterans face in transitioning from the military to civilian occupations

+How serendipity and a sense for untapped markets can lead to unimagined outcomes

+The history of marijuana legislation in the United States

+What BRC brings to the table, and what peer-reviewed medical research could to create more nuanced federal regulation related to marijuana